secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001501697-25-000006
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals closes upsized $85M private placement for mavorixafor development and WHIM commercialization
--------------------------------------------------------------------------------

- Closed private placement of 11,040,776 shares and 48,852,772 pre-funded warrants for gross proceeds of $85M.
- Purchase price per pre-funded warrant is $1.419; exercise price is $0.001 per share; warrants have no expiration.
- Offering upsized from $60M due to pre-existing investment right from one investor; led by Coastlands Capital with support from existing investors.
- Net proceeds to be used for continued development of mavorixafor for chronic neutropenia and commercialization of WHIM.
- Shares and underlying shares to be registered for resale via an SEC registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000006/0001501697-25-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000150169725000006/xfor-20250812.htm
  HTML page:      https://secwatch.observer/filing/0001501697-25-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer